6/12/09 update
The broad market as well as biotechs random-walked their way to another week of gains, although limited ones. At Friday's closing bell the Nasdaq Composite Index was up 18.28% CYTD, or Contest Year To Date, (vs. up 17.68% CYTD a week ago), the Nasdaq Biotech Index was up 1.73% CYTD (vs. up 1.23% CYTD a week ago), while the Contest median was up 15.10% CYTD (vs. up 14.83% CYTD a week ago).
RKRW's portfolio kept its lead with GENE's portfolio remaining in second place and GEORGIA's portfolio holding third place. Friday's closing CYTD eye-popping percentages are: RKRW up 88.38%, GENE up 80.63%, GEORGIA up 69.76%.
At Friday's close, 21 of the 32 Contest portfolios are in the black and 20 of the 32 are beating the NBI.
Have a wonderful weekend folks!
Below is the Top Ten list on 6/12/09:
6/12/09
Rank Name Profit/Loss
1 RKRW 88,377
2 GENE 80,632
3 GEORGIA 69,755
4 MIKE 50,984
5 ROBERT 47,375
6 BULBA 46,723
7 PRAVN 44,300
8 ENZYME 32,869
9 SCARAM 31,034
10 MOPGCW 29,665
Portfolio Revisions: NFLD symbol change to NFLDQ.PK
(All corrections, especially adjustments for splits, greatly appreciated.) |
